Oral Mucositis Market Size and Growth Forecast for Businesses 2025–2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Oral Mucositis Market?

The market for oral mucositis has demonstrated robust expansion in recent years. It is anticipated to increase from $1.44 billion in 2024 to $1.55 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.7%. The expansion observed historically is attributable to an increase in cancer cases, a rise in chemotherapy and radiation treatments, enhanced awareness of oral mucositis, a greater adoption of supportive care therapies, a higher incidence of head and neck cancers, and an increase in research and development within oncology supportive care.

The oral mucositis market is projected to experience substantial growth in the upcoming years, with its valuation anticipated to reach $2.06 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.5%. This expansion throughout the forecast period can be attributed to several factors, including the increasing global incidence of cancer, a rising demand for personalized medical approaches, greater emphasis on palliative care, enhanced patient awareness and education, the broader adoption of over-the-counter oral care solutions, increased governmental and healthcare sector investments, and the growing prevalence of radiation and chemotherapy treatments. Key trends anticipated during this period involve progress in low-level laser therapy, the creation of innovative drug delivery mechanisms, the incorporation of digital health technologies, the application of artificial intelligence in treatment planning, the advancement of tissue engineering and regenerative therapies, and innovations in smart mouthwashes and other oral care products.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21237&type=smp

Which Factors And Drivers Are Influencing The Oral Mucositis Market In 2025?

The escalating incidence of cancer is anticipated to drive the expansion of the oral mucositis market. Cancer, a disease involving the unchecked proliferation and spread of abnormal cells that can damage normal tissues, has seen an increase in prevalence due to factors such as an aging population, lifestyle shifts, environmental exposure, various infections, and genetic predispositions. Oral mucositis therapy offers vital support to cancer patients by alleviating discomfort, reducing inflammation, preventing secondary infections, and fostering quicker healing of oral tissues, which in turn improves their overall comfort, nutritional intake, and quality of life during periods of chemotherapy or radiation treatment. For example, in May 2024, the National Cancer Institute, a US-based government agency, indicated that approximately 20 million new cancer cases and 9.7 million cancer-related deaths were recorded worldwide in 2022. Projections indicate a rise to 29.9 million new cases and 15.3 million deaths annually by 2040. Thus, the rising occurrence of cancer is a key driver for the growth of the oral mucositis market.

What Are The Key Segments In The Oral Mucositis Market?

The oral mucositismarket covered in this report is segmented –

1) By Indication: Chemotherapy; Radiotherapy; Hematopoietic Stem Cell Transplantation

2) By Product Type: Solid Dosage Form; Liquid Dosage Form

3) By Treatment: Palifermin; Amifostine; Chlorhexidine; Sucralfate; Avasopasem; Dusquetide

4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

5) By End User: Hospitals; Dental Clinics; Oncology Hospitals; Research Institutes

Subsegments:

1) By Chemotherapy: High-Dose Chemotherapy-Induced Oral Mucositis; Standard-Dose Chemotherapy-Induced Oral Mucositis

2) By Radiotherapy: Head And Neck Cancer Radiotherapy-Induced Oral Mucositis; Total Body Irradiation-Induced Oral Mucositis

3) By Hematopoietic Stem Cell Transplantation: Autologous Stem Cell Transplantation-Induced Oral Mucositis; Allogeneic Stem Cell Transplantation-Induced Oral Mucositis

How Are Trends Influencing The Oral Mucositis Market?

Leading companies in the oral mucositis market are prioritizing the development of innovative solutions, such as cryotherapy, to mitigate the severity and occurrence of the condition through the application of cold therapy to safeguard oral tissues. Cryotherapy, a medical procedure, involves employing extreme cold to freeze and destroy atypical or diseased tissue, commonly used for ailments like warts, tumors, or injuries. For example, in February 2024, Chemo Mouthpiece LLC, an US-based medical device company, announced the approval of its chemo mouthpiece device by the Food and Drug Administration, an US-based government agency. This chemo mouthpiece is an intraoral ice pack designed to deliver cryotherapy to the oral cavity of patients undergoing chemotherapy. Its purpose is to proactively manage and treat oral mucositis, a prevalent and distressing side effect associated with chemotherapy.

Who Are The Primary Competitors In The Global Oral Mucositis Market?

Major companies operating in the oral mucositis market are Merck & Co Inc., Amgen Inc., Mundipharma International Limited, Swedish Orphan Biovitrum, EUSA Pharma, Galera Therapeutics Inc., Enzychem Lifesciences Corporation, Oragenics Inc., Soligenix Inc., Jaguar Health Inc., Monopar Therapeutics Inc., EpicentRx, BrainCool, Cellceutix Corporation, GlycoMira Therapeutics Inc., Innovation Pharmaceuticals Inc., Allander Biotechnologies, Aurora BioScience, Solasia Pharma KK, NeoMedLight, MuReva (Lumitex), Prothex Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/oral-mucositis-global-market-report

Which Geographies Are Emerging As Strong Markets For The Oral Mucositis Industry?

North America was the largest region in the oral mucositis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral mucositis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Oral Mucositis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21237&type=smp

Browse Through More Reports Similar to the Global Oral Mucositis Market 2025, By The Business Research Company

Oral Biologics And Biosimilar Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilar-drug-global-market-report

Oral Contraceptive Pills Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Oral Thin Films Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795